4.5 Review

Plasmid-mediated quinolone resistance

Journal

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Volume 6, Issue 5, Pages 685-711

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/14787210.6.5.685

Keywords

acetyl transferase; antibiotic resistance; efflux; enterobacteria; pentapeptide-repeat protein; plasmid; qnr; quinolone

Funding

  1. Ministerio de Sanidad y Consumo
  2. Instituto de Salud Carlos III, Spain [PI050690, PI060580]
  3. Consejeria de Innovacion Ciencia y Empresa
  4. Junta de Andalucia, Spain [P07-CTS-02908]
  5. Spanish Network for Research in Infectious Diseases, Spain [REIPI RD06/0008]

Ask authors/readers for more resources

The first plasmid-mediated gene involved in quinolone resistance (qnrA1) was reported in 1998. It codes for a pentapeptide-repeat protein that protects type II topoisomerases from quinolones. Additional related plasmid-mediated genes (qnrB, qnrS and qnrC) and chromosomal homologs of them have also been discovered. Two other plasmid-mediated resistance mechanisms were later reported: modification of quinolones with a piperazinyl substituent by the acetyltransferase Aac(6')-1b-cr and active efflux by QepA, a pump related to the major facilitator superfamily transporters. These genes have a wide geographical distribution (essentially in enterobacteria), although their real prevalence is only partially known because of the difficulty of phenotypic detection of this type of resistance. Although these mechanism cause low-level resistance, they favor and complement the selection of additional mechanisms of resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available